Embryonic Stem Cell-Derived AdipogenesisDani C.
Laboratoire de Biologie du Développement du Tissu Adipeux, Centre de Biochimie (UMR 6543 CNRS), Nice, France
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Key events leading to terminal differentiation of preadipocytes into adipocytes have been characterized in the recent years. However, master genes that commit progression from multipotent mesenchymal stem cell to the adipoblast stage of development have not yet been identified. The use of embryonic stem (ES) cells as a route to study early events in adipogenesis and to characterize factors involved in the decision of stem cells to follow the adipogenic pathway is described in this paper. The capacity of lif–/– and lifr–/– ES cells to undergo adipocyte differentiation is reported as an application of mutant ES cells to study gene function during the development of adipose cells.
© 1999 S. Karger AG, Basel
- Ailhaud, G., P. Grimaldi, R. Négrel (1992) Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr 12: 207–233.
- Anderson, M.S., L.M. Kunkel (1992) The molecular and biochemical basis of Duchenne muscular dystrophy. Trends Biochem Sci 17: 289–292.
Braissant, O., W. Wahli (1998) Differential expression of peroxisome proliferator-activated receptor-α, -β, and -γ during rat embryonic development. Encocrinology 139: 2748–2754.
Casteilla, L., B. Cousin, N. Viguerie-Bascands, D. Larrouy, L. Pénicaud (1994) Hétérogénéité et plasticité cellulaires des tissus adipeux. Médecine Sciences 10: 1099–1106.
- Chambon, P. (1996) A decade of molecular biology of retinoic acid receptors. FASEB J 10: 940–954.
- Chiba, H., J. Clifford, D. Metzger, P. Chambon (1997) Specific and redundant functions of retinoid X receptor/retinoic acid receptor heterodimers in differentiation, proliferation, and apoptosis of F9 embryonal carcinoma cells. J Cell Biol 139: 735–747.
- Cousin, B., S. Cinti, M. Morroni, S. Raimbault, D. Pénicaud, L. Casteilla (1992) Occurrence of brown adipocytes in rat white adipose tissue: Molecular and morphological characterization. J Cell Sci 103: 931–942.
- Dani, C., I. Chambers, S. Johnstone, M. Robertson, B. Ebrahimi, M. Saito, T. Taga, M. Li, T. Burdon, J. Nichols, A. Smith (1998) Paracrine induction of stem cell renewal by LIF-deficient cells: A new ES cell regulatory pathway. Dev Biol 203: 149–162.
- Dani, C., A.G. Smith, S. Dessolin, P. Leroy, L. Staccini, P. Villageois, C. Darimont, G. Ailhaud (1997) Differentiation of embryonic stem cells into adipocytes in vitro. J Cell Sci 110: 1279–1285.
- Doetschman, T.C., H. Eistetter, M. Katz, W. Schmidt, R. Kemler (1985) The in vitro development of blastocyte-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87: 27–45.
- Fried, S.J., R.S. Johnson, R.M. Mortensen, V.E. Papaioannou, B.M. Spiegelman, M.E. Greenberg (1992) Growth and differentiation of embryonic stem cells that lack an intact c-fos gene. Proc Natl Acad Sci USA 89: 9306–9310.
- Gudas, L.J. (1994) Retinoids and vertebrate development. J Biol Chem 269: 15399–15402.
- Hu, E., P. Tontonoz, B.M. Spiegelman (1995) Transdifferentiation of myoblasts by the adipogenic transcription factors PPARγ and C/EBPα. Proc Natl Acad Sci USA 92: 9856–9860.
- Hwang, C.S., T.M. Loftus, S. Mandrup, M.D. Lane (1997) Adipocyte differentiation and leptin expression. Annu Rev Cell Dev Biol 13: 231–259.
- Ibrahimi, A., B. Bertrand, S. Bardon, E.Z. Amri, P. Grimaldi, G. Ailhaud, C. Dani (1993) Cloning of α2 chain of type VI collagen and expression during mouse development. Biochem J 289: 141–147.
Kamei, Y., T. Kawada, J. Mizukami, E. Sugimoto (1994) The prevention of adipose differentiation of 3T3-L1 cells caused by retinoic acid is elicited through retinoic acid receptor alpha. Life Sci 55: 307–312.
- Li, M., M. Sendtner, A. Smith (1995) Essential function of LIF receptor in motor neurons. Nature 378: 724–727.
- Marvulli, D., D. Volpin, G.M. Bressan (1996) Spatial and temporal changes of type VI collagen expression during mouse development. Dev Dyn 206: 447–454.
- Puigserver, P., Z. Wu, C.W. Parl, R. Graves, M. Wright, B.M. Spiegelman (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92: 829–839.
- Ricquier, D., F. Bouillaud (1997) The mitochondrial uncoupling protein: Structural and genetic studies. Prog Nucleic Acid Res Mol Biol 56: 83–108.
- Rohwedel, J., V. Maltsev, E. Bober, H.H. Arnold, J. Hescheler, A.M. Wobus (1994) Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: Developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev Biol 164: 87–101.
- Roy, B., R. Taneja, P. Chambon (1995) Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor α (RARα)-, RARβ-, or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol Cell Biol 15: 6481–6487.
Safonova, I., C. Darimont, E.Z. Amri, P. Grimaldi, G. Ailhaud, U. Reichert, B. Shroot (1994) Retinoids are positive effectors of adipose cell differentiation. Mol Cell Endocrinol 101: 201–211.
- Smas, C.M., H.S. Sul (1995) Control of adipocyte differentiation. Biochem J 309: 697–710.
- Taga, T., T. Kishimoto (1997) gp 130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15: 797–819.
- Tanaka, T., N. Yoshida, T. Kishimoto, S. Akira (1997) Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene. EMBO J 16: 7432–7443.
- Taylor, S.M., P.A. Jones (1979) Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17: 771–779.
- Teboul, L., D. Gaillard, L. Staccini, H. Inadera, E.Z. Amri, P.A. Grimaldi (1995) Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells. J Biol Chem 270: 28183–28187.
- Tontonoz, P., E. Hu, R.A. Graves, A.I. Budavari, B.M. Spiegelman (1994) mPPARγ2:Tissue-specific regulator of an adipocyte enhancer. Genes Dev 8: 1224–1234.
- Tontonoz, P., E. Hu, B.M. Spiegelman (1995) Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor γ. Curr Opin Genet Dev 5: 571–576.
- Wang, N,D., M.J. Finegold, A. Bradley, C.N. Ou, S.V. Abdelsayed, M.D. Wilde, L.R. Taylor, D.R. Wilson, G.J. Darlington (1995) Impaired energy homeostasis in C/EBPα knockout mice. Science 269: 1108–1112.
- Ware, C.B., M.C. Horowitz, B.R. Renshaw, J.S. Hunt, D. Liggitt, S.A. Koblar, B.C. Gliniak, H.H. McKenna, T. Papayannopoulou, B. Thoma, et al. (1995) Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 121: 1283–1299.
- Weintraub, H., S.J. Tapscott, R.L. Davis, M.J. Thayer, M.A. Adam, A.B. Lassar, A.D. Miller (1989) Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci USA 86: 5434–5438.
Young, P., J.R.S. Arch, M. Ashwell (1984) Brown adipose tissue in the parametrial fat pad of the mouse. FEBS Lett 167:10–14.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.